首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

2030189

細胞收集器市場－全球產業規模、佔有率、趨勢、機會、預測：按類型、應用、地區和競爭格局分類，2021-2031年

Cell Harvester Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Application, By Region & Competition, 2021-2031F

出版日期: 2026年05月01日 | 出版商:

TechSci Research | 英文 182 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

全球細胞收穫設備市場預計將以 6.61% 的複合年成長率成長，從 2025 年的 37.8 億美元成長到 2031 年的 55.5 億美元。

這些關鍵設備旨在有效地從生物材料中分離、回收和處理細胞，以用於各種治療和研究用途。市場成長的主要驅動力是再生醫學需求的不斷成長、生物製藥行業的快速發展以及細胞療法在感染疾病和慢性病治療中的廣泛應用。此外，密封系統和自動化技術的進步顯著提高了處理的精確度和效率。生物技術創新組織 (BIO) 的數據凸顯了相關產業的龐大規模，該組織預計到 2025 年，整個生物科學產品市場規模將達到 1.7 兆美元。

市場概覽
預測期	2027-2031
市場規模：2025年	37.8億美元
市場規模：2031年	55.5億美元
複合年成長率：2026-2031年	6.61%
成長最快的細分市場	替換收集器
最大的市場	北美洲

儘管取得了這些積極進展，但最先進的細胞採集設備及相關流程的高昂成本仍然是市場成長的主要障礙。這項財務障礙不僅包括複雜自動化平台所需的初始投資，還包括培訓人員和專用一次性耗材的持續營運成本。

市場促進因素

全球細胞採集器市場的主要驅動力是細胞療法和再生醫學的快速發展。這些前沿治療方法高度依賴高效的細胞採集技術來分離和處理特定細胞，從而對抗疾病。隨著許多基因和細胞療法進入臨床試驗和監管核准階段，對可靠且適應性強的細胞處理方法的需求日益成長。能夠確保最佳細胞純度和活性的採集器對於製備用於移植和注射的細胞至關重要。美國藥品研究與製造商協會（PhRMA）的報告顯示，截至2026年1月，美國有438種基因和細胞療法正在積極研發中，凸顯了對先進處理工具的龐大需求。

此外，一次性使用和自動化技術的突破性進展也對該市場產生了顯著影響。自動化降低了污染風險，提高了一致性，並減少了人工勞動，這些都是生產精密細胞療法的關鍵要素。使用一次性產品，例如一次性試管和試袋，可以簡化流程，縮短處理週期，並透過消除嚴格的滅菌和清洗步驟來降低交叉污染的風險。歐洲生物技術雜誌 (European Biotechnology Magazine) 在 2026 年 2 月報道稱，Zartorius 於 2025 年投資 4.42 億歐元，用於擴大其在亞洲和歐洲的生產，這表明該公司對支持細胞收集的生物製程有著堅定的承諾。此外，Biocom 在 2026 年 3 月報告稱，2025 年生命科學產業的總交易額將達到 3,720 億美元。這反映了該行業的廣泛擴張，而這種擴張是由對新型細胞收集技術的需求所驅動的。

市場挑戰

全球細胞收集器市場成長的主要障礙在於先進細胞收集設備價格高且營運成本高。買家必須預先投入大量資金購買高效能細胞收集和分離所需的自動化平台。此外，專業人員、試劑和專用一次性耗材等持續營運成本也顯著加重了使用者的經濟負擔。如此高的經濟要求限制了市場滲透，尤其是在預算有限的學術實驗室、小規模研究機構和新興生物製藥公司。

先進治療方法所需的巨額資金體現在整個再生醫療產業的大規模投資上，這直接影響到細胞採集器等專業設備的普及。根據再生醫學聯盟預測，到2025年，該產業將透過216輪資金籌措籌集111億美元。細胞採集技術的高昂成本構成了細胞治療研發和生產中心建設及運作所需資金的很大一部分。因此，這種財務現實阻礙了市場擴張，迫使各機構在巨額前期成本、營運預算和預期收益之間謹慎權衡。

市場趨勢

在全球細胞收穫器市場，基因治療和細胞治療產品線的蓬勃發展催生了對高通量處理能力的強勁需求。這一趨勢凸顯了同時處理更大細胞群體和樣本的必要性，從而顯著加快了研發和商業化生產的步伐。高通量收穫技術能夠實現更流暢的操作流程，這對於有效擴大生產規模和保持大規模生產批次的一致性至關重要。例如，根據 News on Projects 2026 年 2 月報道，Cytiva 在印度班加羅爾推出了一座佔地 3 萬平方英尺的生物製程加工廠，旨在加速生物製藥的研發，這正是規模化發展趨勢的一個例證。

同時，數位化監控系統和人工智慧（AI）的引進正在革新細胞收穫領域，顯著提升操作效率和精準度。擺脫傳統的人工檢查，利用數位化設備和AI演算法，可以即時評估最佳收穫時間、生長指標以及細胞的整體健康狀況。透過預測過程異常、減少人為誤差並最大限度地提高細胞活力和產量，這些進步顯著提升了最終產品的可重複性和品質。埃默里大學於2025年12月宣布部署一個價值150萬美元的自動化細胞培養平台，該平台利用AI技術同時追蹤和分析2萬個類器官的細胞分化趨勢，這正是這一趨勢的象徵。

The Global Cell Harvester Market is expected to experience a compound annual growth rate (CAGR) of 6.61%, expanding from USD 3.78 billion in 2025 to USD 5.55 billion by 2031. These vital devices are built to effectively separate, gather, and process cells from biological materials for various therapeutic and research purposes. Market growth is primarily fueled by rising needs in regenerative medicine, a rapidly expanding biopharmaceutical sector, and the wider use of cell-based treatments for infectious and chronic conditions. Furthermore, progress in closed-system and automated technologies greatly improves processing precision and efficiency. The magnitude of the supporting industry is highlighted by the Biotechnology Innovation Organization (BIO), which estimated the wider bioscience product market at $1.7 trillion in 2025.

Market Overview
Forecast Period	2027-2031
Market Size 2025	USD 3.78 Billion
Market Size 2031	USD 5.55 Billion
CAGR 2026-2031	6.61%
Fastest Growing Segment	Displacement Collector
Largest Market	North America

Despite these positive trends, market growth faces a major obstacle due to the steep expenses tied to cutting-edge cell harvesting equipment and related procedures. This financial barrier encompasses both the initial capital required for complex automated platforms and the ongoing operational costs for trained staff and specialized disposable materials.

Market Driver

The Global Cell Harvester Market is largely driven by the rapid growth of cell therapies and regenerative medicine. These cutting-edge treatments rely heavily on effective cell harvesting techniques to isolate and process specific cells for combating diseases. The need for dependable and adaptable cell processing methods grows stronger as an increasing number of gene and cell therapies move toward clinical trials and regulatory clearance. Ensuring optimal cell purity and survival, harvesters are indispensable for readying cells for transplantation and infusion. Emphasizing the massive pipeline in need of sophisticated processing tools, PhRMA reported that 438 gene and cell therapies were actively being developed in the United States as of January 2026.

The market is also heavily influenced by breakthroughs in single-use and automated technologies. Automation lowers contamination threats, boosts consistency, and cuts down on manual work, all of which are essential for producing delicate cell therapies. Utilizing single-use elements like disposable tubing and bags streamlines procedures, speeds up processing cycles, and mitigates cross-contamination hazards by removing the need for rigorous sterilization and cleaning. Showcasing a strong commitment to bioprocessing that aids cell harvesting, European Biotechnology Magazine noted in February 2026 that Sartorius dedicated EUR 442 million in 2025 to expand production in Asia and Europe. Additionally, Biocom reported in March 2026 that the life science industry saw a total deal value of $372 billion in 2025, reflecting the extensive sectoral expansion driving the need for new harvesting technologies.

Market Challenge

A major barrier to the growth of the Global Cell Harvester Market is the steep price of modern cell harvesting equipment and the corresponding procedural expenses. Buyers face heavy initial capital requirements to purchase the automated platforms needed for effective cell gathering and isolation. Moreover, the continuous operational costs tied to expert personnel, reagents, and specialized disposable supplies significantly increase the financial strain on users. Such steep economic requirements restrict wider market penetration, especially for academic labs, smaller research facilities, and nascent biopharmaceutical firms operating on tight budgets.

The massive financial scope of advanced therapies is reflected in the heavy investments needed throughout the regenerative medicine industry, directly affecting the uptake of niche devices like cell harvesters. The Alliance for Regenerative Medicine reported that the sector raised $11.1 billion through 216 financing rounds in 2025. High expenses associated with harvesting technologies form a major part of the capital needed to build and run research and manufacturing centers for cell therapies. Consequently, this financial reality hinders market expansion, forcing organizations to carefully balance large upfront costs against their operating budgets and expected returns.

Market Trends

Within the Global Cell Harvester Market, the growing robust pipeline of gene and cell therapies is creating a strong demand for high-throughput processing capabilities. This movement highlights the necessity to handle larger volumes of cell populations and samples at the same time, which greatly quickens the pace of research, development, and commercial manufacturing. High-throughput harvesting technologies facilitate smoother operational workflows, which are essential for scaling up effectively and maintaining uniformity across massive production batches. Illustrating this shift toward scaled operations, News on Projects highlighted in February 2026 that Cytiva launched a 30,000-square-foot bioprocessing plant in Bengaluru, India, aimed at speeding up biopharmaceutical drug development.

At the same time, cell harvesting is being revolutionized by the incorporation of digital monitoring systems and artificial intelligence, leading to better operational efficiency and accuracy. Moving away from standard manual checks, digital instruments and AI algorithms allow for the real-time assessment of optimal harvesting times, growth metrics, and overall cell health. By predicting process anomalies, lowering human error, and maximizing cell survival and yield, these advancements elevate the reproducibility and quality of the final product. Highlighting this trend, Emory University announced in December 2025 the implementation of a $1.5 million automated cell culture platform that uses AI to concurrently track and analyze 20,000 organoids for cell differentiation trends.

Key Market Players

Human Med AG
ADS Biotec Inc.
PerkinElmer Inc.
TERUMO BCT, INC.
Esco Micro Pte. Ltd.
Gasser Apparatebau und Laborzubehor
Sartorius AG
Cox Scientific Ltd.
Pall Corporation

Report Scope

In this report, the Global Cell Harvester Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cell Harvester Market, By Type

Displacement Collector
Therapy Collector

Cell Harvester Market, By Application

Cell Proliferation Assays
Mixed Lymphocyte Culture (MLC) Assays
Receptor-Binding Assays
Single-Stranded Template DNA Harvesting
Others

Cell Harvester Market, By Region

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cell Harvester Market.

Available Customizations:

Global Cell Harvester Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cell Harvester Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Type (Displacement Collector, Therapy Collector)
- 5.2.2. By Application (Cell Proliferation Assays, Mixed Lymphocyte Culture (MLC) Assays, Receptor-Binding Assays, Single-Stranded Template DNA Harvesting, Others)
- 5.2.3. By Region
- 5.2.4. By Company (2025)
5.3. Market Map

6. North America Cell Harvester Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Type
- 6.2.2. By Application
- 6.2.3. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Cell Harvester Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Type
    - 6.3.1.2.2. By Application
- 6.3.2. Canada Cell Harvester Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Type
    - 6.3.2.2.2. By Application
- 6.3.3. Mexico Cell Harvester Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Type
    - 6.3.3.2.2. By Application

7. Europe Cell Harvester Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Type
- 7.2.2. By Application
- 7.2.3. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Cell Harvester Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Type
    - 7.3.1.2.2. By Application
- 7.3.2. France Cell Harvester Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Type
    - 7.3.2.2.2. By Application
- 7.3.3. United Kingdom Cell Harvester Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Type
    - 7.3.3.2.2. By Application
- 7.3.4. Italy Cell Harvester Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Type
    - 7.3.4.2.2. By Application
- 7.3.5. Spain Cell Harvester Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Type
    - 7.3.5.2.2. By Application

8. Asia Pacific Cell Harvester Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Type
- 8.2.2. By Application
- 8.2.3. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China Cell Harvester Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Type
    - 8.3.1.2.2. By Application
- 8.3.2. India Cell Harvester Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Type
    - 8.3.2.2.2. By Application
- 8.3.3. Japan Cell Harvester Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Type
    - 8.3.3.2.2. By Application
- 8.3.4. South Korea Cell Harvester Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Type
    - 8.3.4.2.2. By Application
- 8.3.5. Australia Cell Harvester Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Type
    - 8.3.5.2.2. By Application

9. Middle East & Africa Cell Harvester Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Type
- 9.2.2. By Application
- 9.2.3. By Country
9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Cell Harvester Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Type
    - 9.3.1.2.2. By Application
- 9.3.2. UAE Cell Harvester Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Type
    - 9.3.2.2.2. By Application
- 9.3.3. South Africa Cell Harvester Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Type
    - 9.3.3.2.2. By Application

10. South America Cell Harvester Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Type
- 10.2.2. By Application
- 10.2.3. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Cell Harvester Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Type
    - 10.3.1.2.2. By Application
- 10.3.2. Colombia Cell Harvester Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Type
    - 10.3.2.2.2. By Application
- 10.3.3. Argentina Cell Harvester Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Type
    - 10.3.3.2.2. By Application

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Cell Harvester Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Human Med AG
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. ADS Biotec Inc.
15.3. PerkinElmer Inc.
15.4. TERUMO BCT, INC.
15.5. Esco Micro Pte. Ltd.
15.6. Gasser Apparatebau und Laborzubehor
15.7. Sartorius AG
15.8. Cox Scientific Ltd.
15.9. Pall Corporation